We are live on
!
Find out more
CRC
Curi RMB Capital Portfolio holdings
AUM
$5.62B
1-Year Est. Return
18.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.52%
1 Year Est. Return
+18.93%
3 Year Est. Return
+60.65%
5 Year Est. Return
+73.12%
10 Year Est. Return
+323.6%
AUM
$2.81B
AUM Growth
+$127M
(+4.7%)
Cap. Flow
-$91.8M
Cap. Flow
% of AUM
-3.26%
Top 10 Holdings %
Top 10 Hldgs %
17.47%
Holding
504
New
39
Increased
117
Reduced
218
Closed
41
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$21.3M |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$14.7M |
| 3 |
Salesforce
CRM
|
+$14M |
| 4 |
iShares MBS ETF
MBB
|
+$11.5M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$7.25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$35M |
| 2 |
STOR
STORE Capital Corporation
STOR
|
+$14.6M |
| 3 |
iShares Expanded Tech-Software Sector ETF
IGV
|
+$14.5M |
| 4 |
TJX Companies
TJX
|
+$8.92M |
| 5 |
Apple
AAPL
|
+$6.46M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22.09% |
| 2 | Technology | 16.43% |
| 3 | Healthcare | 12.41% |
| 4 | Industrials | 9.18% |
| 5 | Consumer Discretionary | 7.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Berkshire Hathaway Class B
BRK.B
$1.12T
| $4.13M | 0.15% |
13,386
+218
| +2% | +$64.7K |
|
152
Old Republic International
ORI
$10.5B
| $4.13M | 0.15% |
170,810
+69,232
| +68% | +$1.62M |
|
153
Gilead Sciences
GILD
$165B
| $4.04M | 0.14% |
47,100
+11,266
| +31% | +$892K |
|
154
Neogen
NEOG
$2.51B
| $3.95M | 0.14% |
259,070
-4,412
| -2% | -$62.8K |
|
155
Pinnacle Financial Partners Inc
PNFP
$16.2B
| $3.94M | 0.14% |
53,622
-31,319
| -37% | -$2.51M |
|
|
AZPN
156
DELISTED
Aspen Technology Inc
AZPN
| $3.91M | 0.14% |
19,042
+728
| +4% | +$169K |
|
157
Markel Group
MKL
$23.2B
| $3.91M | 0.14% |
2,965
-1,701
| -36% | -$2.1M |
|
158
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.81B
| $3.9M | 0.14% |
+160,942
| New | +$3.78M |
|
159
FIVE9
FIVN
$2.23B
| $3.89M | 0.14% |
57,274
-24,721
| -30% | -$1.55M |
|
160
Colony Bankcorp
CBAN
$472M
| $3.81M | 0.14% |
300,000
-16,467
| -5% | -$222K |
|
161
Comcast
CMCSA
$88.1B
| $3.72M | 0.13% |
106,320
+32,861
| +45% | +$1.09M |
|
162
Range Resources
RRC
$9.01B
| $3.68M | 0.13% |
147,148
+125,990
| +595% | +$3.45M |
|
|
WBA
163
DELISTED
Walgreens Boots Alliance
WBA
| $3.66M | 0.13% |
98,092
+56,712
| +137% | +$2.13M |
|
164
Thermo Fisher Scientific
TMO
$213B
| $3.53M | 0.13% |
6,409
-19
| -0.3% | -$10.1K |
|
165
M&T Bank
MTB
$36.3B
| $3.46M | 0.12% |
23,877
+9,616
| +67% | +$1.58M |
|
166
MKS Inc
MKSI
$20.5B
| $3.44M | 0.12% |
40,640
-13,455
| -25% | -$1.08M |
|
167
iShares S&P 500 Growth ETF
IVW
$77.4B
| $3.37M | 0.12% |
57,559
-2,666
| -4% | -$160K |
|
168
iShares Russell 3000 ETF
IWV
$20.3B
| $3.23M | 0.12% |
14,658
+8,344
| +132% | +$1.85M |
|
169
Webster Financial
WBS
$12.9B
| $3.22M | 0.11% |
68,003
-37,771
| -36% | -$1.89M |
|
170
International Flavors & Fragrances
IFF
$21.9B
| $3.22M | 0.11% |
+30,698
| New | +$3.02M |
|
171
Advance Auto Parts
AAP
$3.56B
| $3.21M | 0.11% |
21,823
+5,523
| +34% | +$894K |
|
|
SF
172
Stifel
SF
$12.8B
| $3.15M | 0.11% |
80,975
-23,274
| -22% | -$921K |
|
173
WisdomTree US SmallCap Dividend Fund
DES
$2.23B
| $3.08M | 0.11% |
108,366
-3,417
| -3% | -$98.1K |
|
174
Valmont Industries
VMI
$9.65B
| $3.06M | 0.11% |
9,248
-300
| -3% | -$95.2K |
|
175
First Citizens BancShares
FCNCA
$25.5B
| $3.05M | 0.11% |
4,027
| – | – |
|
Similar funds
AC
RMDI
F
EW
DSC
O
ACM
AS
Curi RMB Capital's Q4 2022 Portfolio in Review
As of Q4 2022, Curi RMB Capital held 504 positions worth $2.81B, up 4.7% from $2.68B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Curi RMB Capital withdrew a net $91.8M in Q4 2022, closing 41 positions and reducing 218 holdings. Its most notable exit was Edwards Lifesciences, an estimated $35M position sold in full.
By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 23% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Curi RMB Capital opened a new position in iShares MBS ETF worth $11.6M.
- Curi RMB Capital's largest Q4 2022 buy was iShares MBS ETF: 125,026 shares worth $11.6M.
- Curi RMB Capital added most to iShares MSCI Emerging Markets ETF in Q4 2022, an estimated $21.3M increase.
- Curi RMB Capital's biggest Q4 2022 reduction was TJX Companies, cutting an estimated $8.92M.
- Curi RMB Capital fully exited Edwards Lifesciences in Q4 2022, selling an estimated $35M.
- Curi RMB Capital's ten largest holdings make up 17% of its $2.81B portfolio in Q4 2022.
- Curi RMB Capital opened 39 new positions and closed 41 in Q4 2022.
- Curi RMB Capital's portfolio value rose 4.7% quarter-over-quarter to $2.81B.
Based on Curi RMB Capital's 13F filing for Q4 2022, filed 14 Feb 2023.